President and CEO of BrainStorm, Chaim Lebovits, expressed the significance of the FDA clearance as a "defining milestone" for both the company and the ALS community. BrainStorm plans to activate ...

Wednesday night, the Omaha Inland Port Authority held a public meeting regarding plans to launch an innovation district in ...

FDA clearance and strategic partnerships position Brainstorm Cell Therapeutics Inc (BCLI) for a significant milestone in ALS research, despite financial hurdles.

Greetings, and welcome to the Brainstorm Cell Therapeutics First Quarter 2025 Conference Call. At this time, all participants ...

President and CEO of BrainStorm, Chaim Lebovits, expressed the significance of the FDA clearance as a "defining milestone" for both the company and the ALS community. BrainStorm plans to activate ...

"This FDA clearance is a defining milestone for BrainStorm and the ALS community," said Chaim Lebovits, President and Chief Executive Officer of BrainStorm. "We are now positioned to swiftly ...

BrainStorm gets US FDA nod to begin phase 3b trial of NurOwn to treat amyotrophic lateral sclerosis: New York Wednesday, May 21, 2025, 18:00 Hrs [IST] BrainStorm Cell Therapeutics ...

It really is this full circular, integrated supply chain that we've created,” said Sip & Sonder co-owner Amanda-Jane Thomas.

After Tropical Storm Helene, the Upper Hickory Nut Gorge Community Center had to be demolished leaving behind many memories ...

BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapies for neurodegenerative ...